Neurocarrus
OperatingNeurocarrus Inc
Biotech
Non-opioid drug treats pain without risk of addiction
Financials
FY2016–FY2025 (no data for FY2021) · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Valuation caps on SAFE / convertible note roundsDashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.
Fundraising history
Team
3 peopleNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 5 of 8 annual reports (FY2018–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGAR- Form C-ARMay 19, 20260001757069-26-000002EDGAR
- Form C-ARMay 8, 20260001757069-26-000001EDGAR
- Form C/AMar 17, 20250001670254-25-000198EDGAR
- Form CJun 12, 20240001670254-24-000695EDGAR
- Form C-ARJun 11, 20240001670254-24-000694EDGAR
- Form C-ARApr 30, 20210001670254-21-000604EDGAR
- Form C-ARApr 27, 20200001670254-20-000300EDGAR
- Form C/AApr 10, 20190001670254-19-000176EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.